Viridian Therapeutics Ors Inc (VRDN)
R&D Expense Growth
-7.80%
Quarterly · Period ending:
VRDN R&D Expense Growth
Latest reported-7.80%period ending
Latest reported-7.80%period ending
VRDN Quarterly R&D Growth (QoQ) (0.00% → -7.80%)
Latest values, visible window
High-resolution chart · PNG
VRDN r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| -7.7984% | |
| -12.9766% | |
| 3.4152% | |
| -0.4214% | |
| 12.7429% | |
| 6.7746% | |
| 4.0516% | |
| 23.0723% | |
| 37.2436% | |
| 6.1908% | |
| 26.8948% | |
| -24.1948% | |
| -21.0032% | |
| 29.0536% | |
| 77.7522% | |
| 1.8745% | |
| 22.3487% | |
| -20.7556% | |
| 175.7542% | |
| -35.3681% | |
| -8.9888% | |
| -9.4926% | |
| 390.3247% | |
| -18.8999% | |
| -37.1457% | |
| -27.492% | |
| -6.7575% | |
| 4.9773% | |
| -1.7369% | |
| 6.2788% | |
| 11.2853% | |
| -11.6537% | |
| 30.5941% | |
| 28.3113% | |
| -0.3986% | |
| -8.5475% | |
| 33.1796% | |
| 19,519.0476% | |
| -90.708% | |
| -32.3353% | |
| 8.7948% | |
| -32.6754% | |
| 80.2372% | |
| 30.4124% | |
| 94% | |
| -30.8972% | |
| 89.8759% | |
| 744.6636% | |
| 3.6293% | |
| 110.202% | |
| -283.1302% | |
| 104.2244% | |
| -50.1126% | |
| 0% |